• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有或未患有2型糖尿病的老年患者的多重疾病:基于初级保健和住院数据的真实世界横断面分析。

Multimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data.

作者信息

Li Yang, Geng Shasha, Yuan Huixiao, Ge Jianli, Li Qingqing, Chen Xin, Zhu Yingqian, Liu Yue, Guo Xiaotong, Wang Xiaoli, Jiang Hua

机构信息

Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

Department of Geriatrics, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

出版信息

J Glob Health. 2024 Dec 20;14:04263. doi: 10.7189/jogh.14.04263.

DOI:10.7189/jogh.14.04263
PMID:39700381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11658714/
Abstract

BACKGROUND

Shanghai's high level of ageing has given rise to a considerable number of elderly patients with type 2 diabetes mellitus (T2DM) who are confronted with the challenge of managing multimorbidity. We aimed to determine the prevalence of multimorbidity in elderly T2DM patients in a representative Pudong New Area community and critically evaluate current guidelines' inclusiveness in addressing major comorbidities.

METHODS

Through the Shanghai Health Cloud platform, we extracted medical records of residents in the Huamu community (Pudong New Area, Shanghai) to screen elderly patients with at least three outpatient visits or one hospitalisation per year between 2019 and 2022. According to International Classification of Disease, 10th edition codes and personal identification number, we identified the status of T2DM and 12 other common chronic diseases, matched T2DM patients and non-T2DM patients 1:1 by age and gender, and then calculated the prevalence of multimorbidity status and annual prevalence of each comorbidity. We analysed associations between T2DM and specific chronic diseases using logistic regression models.

RESULTS

More than 90% of elderly T2DM patients had at least one additional chronic disease. Multimorbidity was more frequent in women and older patients. Hyperlipidemia, hypertension, and ischaemic heart disease were the most prevalent comorbidities. The diagnosis of T2DM was significantly associated with both cardiovascular-kidney-metabolic and neuropsychiatric diseases. In addition, a higher prevalence and risk of chronic obstructive pulmonary disease (COPD) were consistently detected in elderly patients with T2DM, regardless of age and gender.

CONCLUSIONS

Multimorbidity in elderly patients with T2DM needs broader acknowledgement. Current guidelines focus more on cardiovascular-kidney-metabolic and neuropsychiatric diseases with inadequate guidance on COPD management. Hence, the pleiotropic effects of glucose-lowering drugs on COPD should be further investigated to optimise the comprehensive management strategy for this population.

摘要

背景

上海的高度老龄化导致大量老年2型糖尿病(T2DM)患者面临多重疾病管理的挑战。我们旨在确定浦东新区一个具有代表性社区中老年T2DM患者的多重疾病患病率,并严格评估现行指南在解决主要合并症方面的包容性。

方法

通过上海健康云平台,我们提取了花木社区(上海浦东新区)居民的医疗记录,以筛选出在2019年至2022年期间每年至少有三次门诊就诊或一次住院治疗的老年患者。根据国际疾病分类第10版编码和个人识别码,我们确定了T2DM和其他12种常见慢性病的状况,按年龄和性别将T2DM患者与非T2DM患者1:1匹配,然后计算多重疾病状况的患病率和每种合并症的年患病率。我们使用逻辑回归模型分析T2DM与特定慢性病之间的关联。

结果

超过90%的老年T2DM患者至少患有一种其他慢性病。多重疾病在女性和老年患者中更为常见。高脂血症、高血压和缺血性心脏病是最常见的合并症。T2DM的诊断与心血管-肾脏-代谢疾病和神经精神疾病均显著相关。此外,无论年龄和性别,在老年T2DM患者中始终检测到较高的慢性阻塞性肺疾病(COPD)患病率和风险。

结论

老年T2DM患者的多重疾病需要得到更广泛的认识。现行指南更多地关注心血管-肾脏-代谢疾病和神经精神疾病,而对COPD管理的指导不足。因此,应进一步研究降糖药物对COPD的多效性作用,以优化该人群的综合管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/a5f8b19ee9bb/jogh-14-04263-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/ec17613d7eb6/jogh-14-04263-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/b6d666f889a8/jogh-14-04263-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/03343e2817e5/jogh-14-04263-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/558a466807aa/jogh-14-04263-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/a5f8b19ee9bb/jogh-14-04263-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/ec17613d7eb6/jogh-14-04263-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/b6d666f889a8/jogh-14-04263-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/03343e2817e5/jogh-14-04263-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/558a466807aa/jogh-14-04263-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebaf/11658714/a5f8b19ee9bb/jogh-14-04263-F5.jpg

相似文献

1
Multimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data.患有或未患有2型糖尿病的老年患者的多重疾病:基于初级保健和住院数据的真实世界横断面分析。
J Glob Health. 2024 Dec 20;14:04263. doi: 10.7189/jogh.14.04263.
2
Patterns of multimorbidity in community health centres in Shanghai, China: a retrospective, cross-sectional study based on outpatient data from 2014 to 2018.中国上海社区卫生中心的多病共存模式:基于 2014 年至 2018 年门诊数据的回顾性、横断面研究。
BMJ Open. 2022 Oct 5;12(10):e048727. doi: 10.1136/bmjopen-2021-048727.
3
Real-world study of the multimorbidity and health service utilisation among individuals with non-diabetic hyperglycemia and type 2 diabetes mellitus in North West London.真实世界研究:伦敦西北部非糖尿病高血糖个体与 2 型糖尿病患者的共病情况及卫生服务利用。
BMJ Open Diabetes Res Care. 2024 Aug 8;12(4):e003873. doi: 10.1136/bmjdrc-2023-003873.
4
Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England.有和无血管并发症的 2 型糖尿病患者的就诊率:对英格兰 141328 名成年人的回顾性分析。
Cardiovasc Diabetol. 2022 Jan 10;21(1):8. doi: 10.1186/s12933-021-01435-y.
5
Multimorbidity in people with type 2 diabetes in the Basque Country (Spain): Prevalence, comorbidity clusters and comparison with other chronic patients.西班牙巴斯克地区2型糖尿病患者的多重疾病:患病率、共病集群及与其他慢性病患者的比较
Eur J Intern Med. 2015 Apr;26(3):197-202. doi: 10.1016/j.ejim.2015.02.005. Epub 2015 Feb 17.
6
Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data.637255 例 2 型糖尿病患者和非 2 型糖尿病患者的 11 年多病种负担:基于人群的使用初级保健和相关住院数据的研究。
BMJ Open. 2020 Jul 1;10(7):e033866. doi: 10.1136/bmjopen-2019-033866.
7
Multimorbidity in the community-dwelling elderly in urban China.中国城市社区老年人的多重疾病状况。
Arch Gerontol Geriatr. 2017 Jan-Feb;68:62-67. doi: 10.1016/j.archger.2016.09.001. Epub 2016 Sep 14.
8
Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database.基于 3B 研究数据库的横断面、多中心、回顾性、观察性研究:中国成年 2 型糖尿病患者合并症的患病率和共患病率。
Front Endocrinol (Lausanne). 2024 Jun 11;15:1362433. doi: 10.3389/fendo.2024.1362433. eCollection 2024.
9
Prevalence and patterns of multimorbidity in chronic diseases in Guangzhou, China: a data mining study in the residents' health records system among 31 708 community-dwelling elderly people.中国广州慢性疾病的多病共存现状和模式:基于 31708 名社区居住老年人健康记录系统的数据分析研究。
BMJ Open. 2022 May 25;12(5):e056135. doi: 10.1136/bmjopen-2021-056135.
10
The association between multimorbidity and health-related quality of life: a cross-sectional survey among community middle-aged and elderly residents in southern China.多种疾病共存与健康相关生活质量的关系:中国南方社区中年和老年居民的横断面调查。
Health Qual Life Outcomes. 2019 Jun 24;17(1):107. doi: 10.1186/s12955-019-1175-0.

本文引用的文献

1
Nephroprotective effect of SGLT2 inhibitors in elderly patients with type 2 diabetes mellitus and hypertension: a real-world population-based cohort study.SGLT2 抑制剂在老年 2 型糖尿病合并高血压患者中的肾脏保护作用:一项真实世界基于人群的队列研究。
Postgrad Med. 2024 Nov;136(8):855-863. doi: 10.1080/00325481.2024.2426442. Epub 2024 Nov 13.
2
Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition).《中国老年糖尿病诊疗指南(2024年版)》
Aging Med (Milton). 2024 Mar 29;7(1):5-51. doi: 10.1002/agm2.12294. eCollection 2024 Feb.
3
Prevalence and patterns of multimorbidity in China during 2002-2022: A systematic review and meta-analysis.
2002-2022 年中国多模态疾病的流行状况和模式:系统评价和荟萃分析。
Ageing Res Rev. 2024 Jan;93:102165. doi: 10.1016/j.arr.2023.102165. Epub 2023 Dec 12.
4
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.4. 合并症的综合医学评估:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S52-S76. doi: 10.2337/dc24-S004.
5
Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge.糖尿病与多种长期疾病:对当前全球健康挑战的回顾。
Diabetes Care. 2023 Dec 1;46(12):2092-2101. doi: 10.2337/dci23-0035.
6
A network-based study reveals multimorbidity patterns in people with type 2 diabetes.一项基于网络的研究揭示了2型糖尿病患者的多种合并症模式。
iScience. 2023 Sep 20;26(10):107979. doi: 10.1016/j.isci.2023.107979. eCollection 2023 Oct 20.
7
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.心血管-肾脏-代谢健康:美国心脏协会的总统顾问报告
Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.
8
COPD and multimorbidity: recognising and addressing a syndemic occurrence.COPD 与多种共病:识别和应对综合征发生。
Lancet Respir Med. 2023 Nov;11(11):1020-1034. doi: 10.1016/S2213-2600(23)00261-8. Epub 2023 Sep 8.
9
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.
10
Evaluation of the reported data linkage process and associated quality issues for linked routinely collected healthcare data in multimorbidity research: a systematic methodology review.评价多疾病研究中报告的数据链接过程及相关质量问题:系统方法学综述。
BMJ Open. 2023 May 8;13(5):e069212. doi: 10.1136/bmjopen-2022-069212.